1059 patients were enrolled and randomly assigned between Nov 11 , 2009 , and Nov 23 , 2011 ( 533 to the lenalidomide group and 526 to the control group ) , and 1046 patients received study treatment ( 525 in the lenalidomide group and 521 in the placebo group ) .